Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cerilliant
AstraZeneca
Farmers Insurance
US Army
Chubb
Boehringer Ingelheim
Cipla
Healthtrust
Federal Trade Commission

Generated: December 11, 2017

DrugPatentWatch Database Preview

Lidocaine; prilocaine - Generic Drug Details

« Back to Dashboard

What are the generic sources for lidocaine; prilocaine and what is the scope of lidocaine; prilocaine patent protection?

Lidocaine; prilocaine
is the generic ingredient in three branded drugs marketed by Actavis Labs Ut Inc, Fougera Pharms, Hi Tech Pharma, Tolmar, Astrazeneca, and Dentsply Pharm, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine; prilocaine has thirty-three patent family members in twenty-nine countries.

There are twenty-nine drug master file entries for lidocaine; prilocaine. Twenty-five suppliers are listed for this compound.

Summary for lidocaine; prilocaine

Pharmacology for lidocaine; prilocaine

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut IncEMLAlidocaine; prilocaineCREAM;TOPICAL019941-001Dec 30, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
AstrazenecaEMLAlidocaine; prilocaineDISC;TOPICAL020962-001Feb 4, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hi Tech PharmaLIDOCAINE AND PRILOCAINElidocaine; prilocaineCREAM;TOPICAL076290-001Sep 25, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dentsply PharmORAQIXlidocaine; prilocaineGEL;PERIODONTAL021451-001Dec 19, 2003RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Fougera PharmsLIDOCAINE AND PRILOCAINElidocaine; prilocaineCREAM;TOPICAL076453-001Aug 18, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TolmarLIDOCAINE AND PRILOCAINElidocaine; prilocaineCREAM;TOPICAL076320-001Aug 27, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine; prilocaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut IncEMLAlidocaine; prilocaineCREAM;TOPICAL019941-001Dec 30, 1992► Subscribe► Subscribe
Dentsply PharmORAQIXlidocaine; prilocaineGEL;PERIODONTAL021451-001Dec 19, 2003► Subscribe► Subscribe
Actavis Labs Ut IncEMLAlidocaine; prilocaineCREAM;TOPICAL019941-001Dec 30, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine; prilocaine

Country Document Number Estimated Expiration
Slovakia169897► Subscribe
Brazil9702147► Subscribe
Russian Federation2185153► Subscribe
China1149072► Subscribe
Spain2203799► Subscribe
Canada2222676► Subscribe
Japan2004149544► Subscribe
Australia2416897► Subscribe
Sweden9601421► Subscribe
New Zealand329246► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Fuji
Chinese Patent Office
UBS
Teva
Cerilliant
US Department of Justice
Novartis
AstraZeneca
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot